Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 1
2006 2
2007 3
2008 4
2009 4
2010 1
2011 1
2012 3
2013 2
2014 2
2015 1
2016 3
2018 3
2019 1
2020 3
2021 6
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.
Merino B, Casanueva-Álvarez E, Quesada I, González-Casimiro CM, Fernández-Díaz CM, Postigo-Casado T, Leissring MA, Kaestner KH, Perdomo G, Cózar-Castellano I. Merino B, et al. Among authors: leissring ma. Diabetologia. 2024 Jan;67(1):218-219. doi: 10.1007/s00125-023-06037-9. Diabetologia. 2024. PMID: 37966551 Free PMC article. No abstract available.
Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: Implications for Alzheimer disease pathogenesis.
Terron HM, Parikh SJ, Abdul-Hay SO, Sahara T, Kang D, Dickson DW, Saftig P, LaFerla FM, Lane S, Leissring MA. Terron HM, et al. Among authors: leissring ma. Res Sq [Preprint]. 2023 Oct 23:rs.3.rs-3464352. doi: 10.21203/rs.3.rs-3464352/v1. Res Sq. 2023. PMID: 37961253 Free PMC article. Updated. Preprint.
Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.
Merino B, Casanueva-Álvarez E, Quesada I, González-Casimiro CM, Fernández-Díaz CM, Postigo-Casado T, Leissring MA, Kaestner KH, Perdomo G, Cózar-Castellano I. Merino B, et al. Among authors: leissring ma. Diabetologia. 2022 Aug;65(8):1375-1389. doi: 10.1007/s00125-022-05729-y. Epub 2022 Jun 2. Diabetologia. 2022. PMID: 35652923 Free PMC article.
Hydroxypyridinethione Inhibitors of Human Insulin-Degrading Enzyme.
Adamek RN, Suire CN, Stokes RW, Brizuela MK, Cohen SM, Leissring MA. Adamek RN, et al. Among authors: leissring ma. ChemMedChem. 2021 Jun 7;16(11):1775-1787. doi: 10.1002/cmdc.202100111. Epub 2021 Mar 31. ChemMedChem. 2021. PMID: 33686743 Free PMC article.
Targeting Insulin-Degrading Enzyme in Insulin Clearance.
Leissring MA, González-Casimiro CM, Merino B, Suire CN, Perdomo G. Leissring MA, et al. Int J Mol Sci. 2021 Feb 24;22(5):2235. doi: 10.3390/ijms22052235. Int J Mol Sci. 2021. PMID: 33668109 Free PMC article. Review.
51 results